Physician profile
Madison Beatty
NPI 1457887507
$985.49
in general payments reported to CMS, 2019-2025
17 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.32 · 2021: $27.78 · 2022: $195 · 2023: $161 · 2024: $356 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $216.90 | 2021-2025 | |
| Novo Nordisk INC | $148.19 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $119.72 | 2023-2025 | |
| Pfizer INC. | $103.95 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $52.80 | 2024 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $51.92 | 2022-2023 | |
| Lilly USA, LLC | $46.56 | 2022-2025 | Zepbound, Mounjaro |
| Mylan Specialty L.P. | $44.42 | 2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $43.38 | 2022-2023 | Eliquis |
| Amgen INC. | $32.43 | 2024-2025 | Evenity, Prolia, Prolia |
| Viatris Specialty LLC | $21.62 | 2025 | Yupelri |
| Exact Sciences Corporation | $19.06 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $19.02 | 2023 | Veozah |
| Glaxosmithkline, LLC. | $18.58 | 2024 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $17.56 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $15.32 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.06 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Beatty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.